about
Reliability of HLA-Cw data collected in unrelated bone marrow registry and their usefulness for preliminary donor selection.Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated CytotoxicityPotential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.Host immune response in B-cell lymphomas: friend or foe?Role of HLA in hematopoietic SCT.DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.The patterns of MHC association in aplastic and non-aplastic paroxysmal nocturnal hemoglobinuria.Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome.IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations.Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients[Twenty-four hour monitoring of electrocardiogram in patients with rheumatoid arthritis]Influence of increased environmental temperature on oxidation processes in rat liver mitochondria24-h ECG monitoring in patients with rheumatoid arthritisAtopic diseases in a pair of monozygotic twins[Echocardiographic evaluation of cardiac structures in patients with rheumatoid arthritis]Leucocyte antibodies in blood donors and a look back on recipients of their blood componentsCCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donorHLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donorRole of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantationEpstein-Barr virus infections are strongly dependent on activating and inhibitory KIR-HLA pairs after T-cell replate unrelated hematopoietic stem cell transplantation, the principles, and method of pairing analysisHigh-resolution allele frequencies for NGS based HLA-A, B, C, DQB1 and DRB1 typing of 23,595 bone marrow donors recruited for the Polish central potential unrelated bone marrow donor registryKIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules
P50
Q31004732-9D0FA04D-468B-4C71-8B99-429F42C1F533Q36606370-D65DE29E-EA72-42C7-A1C6-E35369FCB471Q36695249-DF5AF0E7-246A-4BED-B677-FE771AACE758Q37251809-1800B5C5-7376-46C2-A68E-016E1B55F550Q37315413-33D0A85F-BC95-452D-A929-8DA75E9762F1Q37397544-5468CB3C-D2C1-4F78-81F5-26A3D7A1B0A8Q39117286-E4AA6D02-8679-4870-BC46-A9ABB24CAC6EQ40457401-D8B8E431-0754-4C0F-8E55-108FBEC99E90Q41532474-BA65AA20-3955-4058-8110-4F5733964F5CQ41732815-F6C84EBA-3F88-4877-B2EA-A70A2D66E6D6Q42248606-7408FC6A-2317-4BD7-B4E5-BB18D1FF8187Q43803822-E4B11D3A-B3DB-41FB-B945-009A43992EC5Q44452652-DC31E2CD-06A4-4A04-8F76-C026A52BB7D3Q46812391-08C8F0E7-310A-4063-B838-DB97424FADB3Q48846219-29862C73-4E43-4134-8279-D397BEB9FFECQ51897230-274901A8-E76D-40A9-BFCE-C1DAF90E8F93Q64277503-112CB5A2-FE62-40B0-BE28-43B2E8B3036AQ67830354-7B1AF717-0E8A-4CA9-BCFE-A1B7F8344249Q70181240-53604703-B4B3-45E8-826E-64AD6A400AF6Q71814734-78D0FF1C-1D30-4496-A983-2AD7AD67FC59Q73192575-4C21E19B-6DF5-44A2-BFF2-1DDB2A1B7096Q73973660-2DE297D6-DF07-41AE-AFCF-08ADB6D33DB7Q79912790-FAD26887-A735-4676-A887-139D4C48F2D2Q87020433-1549E0DA-EE9B-4F1A-BE6B-4FD6908CAC30Q88236777-DAB9BE99-854E-4953-9DBA-58D63D823441Q91245472-025AFA05-B4D9-4930-B2DF-D8BD7AC32CC1Q91409678-FA54A8D6-3961-4B47-B135-75DBDD8C2874Q92420840-FC8EC702-0B0C-48E5-82B9-1063DE63C85BQ92835861-082A0264-F2BC-4222-95B8-B34DA20888B3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jacek Nowak
@ast
Jacek Nowak
@en
Jacek Nowak
@es
Jacek Nowak
@sl
type
label
Jacek Nowak
@ast
Jacek Nowak
@en
Jacek Nowak
@es
Jacek Nowak
@sl
prefLabel
Jacek Nowak
@ast
Jacek Nowak
@en
Jacek Nowak
@es
Jacek Nowak
@sl
P214
P106
P1153
7202097083
P1960
lLCFKb0AAAAJ
P2038
Jacek_Nowak
P21
P213
0000 0001 1385 8311
P214
P31
P3835
jacek-nowak3
P496
0000-0002-3474-7597
P734
P735
P7859
viaf-166461901